In the United States, plan to treat post-traumatic syndrome with ecstasy

The US Food and Drug Administration's Food and Drug Administration has called the use of ecstasy in the post-traumatic syndrome "therapy-breakthrough".

The fact that MDMA or otherwise - ecstasy, may be effective in the treatment of PTSD (post-traumatic syndrome) has been known over the past 40 years, reports Sciencealert.

Due to the fact that the relevant agency of the US Department of Health has determined the effectiveness of such therapy, the chances that a drug will be accepted as a pharmaceutical preparation has increased.

Recall British scientists received approval from the ethical committee for the first world clinical trials of alcohol dependence therapy using ecstasy (methylenedioxymethamphetamine MDMA, MDMA).

hromadske.ua, Original in Ukrainian / Українською мовою